What are the grades of gynecomastia and the recommended management for each grade?

Gynecomastia Grading and Management

Most gynecomastia can be diagnosed clinically without imaging, and management is determined by the grade of tissue involvement and skin excess, ranging from observation for physiologic cases to surgical intervention combining liposuction with glandular excision for higher grades.

Classification Systems

The most widely used classification is the Simon grading system, which stratifies gynecomastia based on breast enlargement and skin excess 1:

• Grade I: Minor breast enlargement without skin excess (primarily glandular tissue, <250g)
• Grade IIa: Moderate breast enlargement without skin excess (250-500g)
• Grade IIb: Moderate breast enlargement with minor skin excess
• Grade III: Marked breast enlargement with significant skin excess and ptosis (>500g)

Some sources also describe Grade IV (massive enlargement with severe ptosis) 2.

On mammography, three patterns exist: (1) nodular (subareolar nodule), (2) dendritic (flame-shaped), and (3) diffuse glandular 3.

Initial Evaluation

Clinical diagnosis is sufficient in most cases; imaging is NOT routinely indicated 3. When physical examination clearly demonstrates the soft, rubbery, mobile subareolar mass characteristic of gynecomastia, proceed directly to management decisions.

When to Image:

• Indeterminate clinical findings where malignancy cannot be excluded
• Suspicious features (hard mass, eccentric location, skin/nipple changes, bloody discharge)
• Age >25 years with unilateral presentation
• Ultrasound is preferred initial imaging in men <25 years; mammography in older men 3

Laboratory Workup:

Essential tests include total testosterone, estradiol, LH, hCG, and prolactin. Add FSH, TSH, liver/kidney function, and testicular ultrasound as clinically indicated 4.

Management Algorithm by Grade

Grade I (Minor, No Skin Excess)

Primary approach: Liposuction alone 1, 5, 6

• Suction-assisted or ultrasound-assisted liposuction through small periareolar or inframammary incisions
• Success rate 86.9% with minimal scarring 1
• May add minimal periareolar glandular excision if firm central disc persists 5
• Observation is appropriate for physiologic gynecomastia in neonates, adolescents, or elderly men if asymptomatic 4

Grade IIa (Moderate, No Skin Excess)

Combined approach: Liposuction + subcutaneous mastectomy 5, 6

• Liposuction first (median 300ml aspirated per breast) 5
• Periareolar incision for glandular tissue excision (median 25g removed) 5
• This combination provides excellent outcomes with low complication rates (3.8% in recent series) 5
• Ultrasound-assisted liposuction particularly effective for dense fibrous tissue 1

Grade IIb (Moderate with Minor Skin Excess)

Combined approach with consideration for skin tightening 7, 8

• Liposuction + glandular excision as above
• Add periareolar deepithelialization/mastopexy if needed 8
• Internal quilting sutures to manage mild skin redundancy 8
• Avoid extensive skin excision if possible to minimize scarring

Grade III (Marked Enlargement with Significant Skin Excess)

Subcutaneous mastectomy with circumareolar concentric skin reduction 9, 6, 2

• Single-stage procedure combining glandular excision with periareolar skin resection
• Crescentic lift for nipple repositioning when ptosis present 2
• Accept mild residual skin redundancy rather than extensive scarring—patients typically satisfied without secondary procedures 9
• Reserve formal mastectomy with free nipple graft only for extreme cases (massive weight loss, tubular breast deformity) 9

Grade IV (Massive Enlargement)

VASER liposuction + glandular excision + crescentic NAC lift 2

• Grade IVa (without severe ptosis): Liposuction and excision achieve symmetry in 95% 2
• Grade IVb (with severe ptosis): Add crescentic lift; corrects ptosis in 83% 2
• Only 8.6% desire secondary procedures at mean 15-month follow-up 2
• Set realistic expectations preoperatively—Grade IVb has more residual deformity than IVa

Critical Management Principles

Medical Management

Medical therapy (tamoxifen, aromatase inhibitors) has limited success and is not standard treatment 1. Surgery remains the definitive approach for symptomatic or cosmetically concerning gynecomastia.

Surgical Timing

• Physiologic gynecomastia: Observe for 12-24 months before intervention (often resolves spontaneously in adolescents)
• Painful gynecomastia: More likely if present <6 months; may respond to observation 3
• Persistent cases: Proceed to surgery after addressing underlying causes

Common Pitfalls

• Over-imaging: Do not routinely order mammography or ultrasound for clinically obvious gynecomastia 3
• Under-resection: Leaving residual glandular tissue leads to recurrence
• Over-resection: Creates contour deformities and nipple retraction
• Excessive skin excision: Produces visible scars; accept mild redundancy over conspicuous scarring 9
• Missing malignancy: 50% of male breast cancers have coexisting gynecomastia; maintain high suspicion for hard, eccentric, or rapidly growing masses 3

Malignancy Exclusion

Breast cancer occurs in <1% of males but presents at advanced stages 3. Red flags requiring imaging/biopsy:

• Unilateral, eccentric, hard mass
• Skin/nipple retraction or discharge
• Rapid growth
• Age >40 years with new-onset unilateral findings
• Palpable lymphadenopathy

Gynecomastia itself is not a risk factor for male breast cancer 3.